Public Calendar: May 5-11, 2024
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs
Event Date: 05/06/2024
Location: Virtual
Subject: 2024 Spring Alzheimer's Disease Research Centers Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, and other registered attendees
Event Date: 05/07/2024
Location: Washington, DC
Subject: Reagan-Udall Foundation Annual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, government, media, and other registered attendees
Event Date: 05/09/2024
Location: Bethesda, MD
Subject: National Institutes of Health Pragmatic Trials Collaboratory Steering Committee Meeting
FDA Participant/Group: LEONARD SACKS; KEVIN BUGIN; ALEXANDER WOHL;
Non FDA Participant/Group: Academia, government and other invited attendees
Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner
Event Date: 05/06/2024
Location: Washington, DC
Subject: Friends of Cancer Research (FOCR) and the Parker Institute for Cancer Immunotherapy (PICI) Public Meeting - Unlocking Complex Cell-Based Gene Therapies; Opening Keynote Conversation
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Industry, academia, regulatory, and other stakeholders
Event Date: 05/08/2024
Location: Virtual
Subject: Society of Toxicology and FDA Colloquia on Emerging Toxicological Science: Challenges in Food and Ingredient Safety; Current State of the Science: Toxicology of Cannabidiol and Other Cannabinoids
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, regulatory, other stakeholders
Event Date: 05/08/2024
Location: Washington, DC
Subject: Democratic Women’s Caucus Cosmetic Safety Roundtable; Panelist
FDA Participant/Group: N/A
Non FDA Participant/Group: Various members of Congress, staff members, and advocacy stakeholders
Event Date: 05/09/2024
Location: Washington, DC
Subject: National Health Council (NHC) 2024 Science of Patient Engagement Symposium (SPES); Speaker: Final Keynote
FDA Participant/Group: N/A
Non FDA Participant/Group: Researchers, academia, and other stakeholders
Official Name: Jim Jones, Deputy Commissioner for Human Foods
Event Date: 05/07/2024
Location: Washington DC
Subject: Western Growers Fly-In Event; Speaker: FDA Human Foods Program Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Western Growers staff and member companies
Event Date: 05/09/2024
Location: Bedford Park, IL
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Staff and Executive Advisory Board members of Illinois Tech's Institute for Food Safety and Health
Event Date: 05/09/2024
Location: Rosemont, IL
Subject: Food Safety Summit 2024; Panelist: FDA Human Foods Program Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, researchers, policymakers, and experts
Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Leah Hunter, Associate Commissioner for External Affairs
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 05/06/2024
Location: Virtual
Subject: Alliance for a Stronger FDA, FY25 Budget Series; Center for Drug Evaluation and Research
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Alliance for a Stronger FDA
Event Date: 05/10/2024
Location: Virtual
Subject: Listening Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Cystic Fibrosis Foundation (CFF)
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 05/08/2024
Location: Baltimore, MD
Subject: American Society of Gene and Cell Therapy 27th Annual Meeting; Fireside Chat: Regulating Cell and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the American Society of Gene and Cell Therapy 27th Annual Meeting
Event Date: 05/08/2024
Location: Virtual
Subject: Advanced Therapies Medicinal Products (Beijing) Forum 2024; Speaker: The Future of Human Genome Editing, A Regulatory Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Advanced Therapies Medicinal Products (Beijing) Forum 2024: Global RNA, Gene and Cellular Immunotherapy Innovators of Beijing Forum 2024
Event Date: 05/08/2024
Location: Washington, DC
Subject: Stanford Biodesign Policy Program Health Technology Innovation Policy Conference 2024; Speaker: Current Policy Challenges Impacting Biotechnology Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Stanford Biodesign Policy Program Health Technology Innovation Policy Conference 2024
Event Date: 05/09/2024
Location: Virtual
Subject: Blood Products Advisory Committee Meeting
FDA Participant/Group: ANNE EDER;
Non FDA Participant/Group: Attendees of the Blood Products Advisory Committee Meeting
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition
Event Date: 05/06/2024
Location: Virtual
Subject: World Health Organization (WHO) Public Health Risk of Avian Influenza Detected Recently in Dairy Cattle Webinar
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Various WHO representatives
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
Event Date: 05/08/2024
Location: Newark, DE
Subject: American Lung Association’s Tobacco-Free for Every Delawarean Conference; Keynote Address: FDA's Comprehensive Approach to Tobacco Product Regulation
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the American Lung Association and other conference attendees
Event Date: 05/08/2024
Location: Newark, DE
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Aleks Casper, Deb Brown (American Lung Association);
Event Date: 05/09/2024
Location: Washington, DC
Subject: 2024 Youth Advocates of the Year Awards
FDA Participant/Group: N/A
Non FDA Participant/Group: Widely attended gathering
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
No Significant Event
Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event